Literature DB >> 20364371

Paracoccidioides brasiliensis uses endogenous and exogenous arachidonic acid for PGE x production.

Guilherme Augusto Biondo1, Luciane Alarcão Dias-Melicio, Ana Paula Bordon-Graciani, Michele Janegitz Acorci-Valério, Angela Maria Victoriano Campos Soares.   

Abstract

Paracoccidioides brasiliensis is the agent of paracoccidioidomycosis, the most prevalent deep mycosis in Latin America. Production of eicosanoids during fungal infections plays a critical role on fungal biology as well as on host immune response modulation. The purpose of our study was to assess whether P. brasiliensis strains with different degree of virulence (Pb18, Pb265, Bt79, Pb192) produce prostaglandin E(x) (PGE(x)). Moreover, we asked if P. brasiliensis could use exogenous sources of arachidonic acid (AA), as well as metabolic pathways dependent on cyclooxygenase (COX) enzyme, as reported for mammalian cells. A possible association between this prostanoid and fungus viability was also assessed. Our results showed that all strains, independently of their virulence, produce high PGE(x) levels on 4 h culture that were reduced after 8 h. However, in both culture times, higher prostanoid levels were detected after supplementation of medium with exogenous AA. Treatment with indomethacin, a COX inhibitor, induced a reduction on PGEx, as well as in fungus viability. The data provide evidence that P. brasiliensis produces prostaglandin-like molecules by metabolizing either endogenous or exogenous AA. Moreover, the results suggest the involvement of these mediators on fungal viability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20364371     DOI: 10.1007/s11046-010-9301-x

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  29 in total

Review 1.  Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators.

Authors:  Hedi Harizi; Norbert Gualde
Journal:  Cell Mol Immunol       Date:  2006-08       Impact factor: 11.530

2.  Discriminant analysis of cellular fatty acids of Candida species, Torulopsis glabrata, and Cryptococcus neoformans determined by gas-liquid chromatography.

Authors:  K Marumo; Y Aoki
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Prostaglandin E2 inhibits Paracoccidioides brasiliensis killing by human monocytes.

Authors:  Ana Paula Bordon; Luciane Alarcão Dias-Melicio; Michele Janegitz Acorci; Sueli Aparecida Calvi; Maria Terezinha Serrão Peraçoli; Angela Maria Victoriano de Campos Soares
Journal:  Microbes Infect       Date:  2007-02-24       Impact factor: 2.700

Review 4.  Cyclooxygenases and prostaglandins: shaping up the immune response.

Authors:  Bianca Rocca; Garret A FitzGerald
Journal:  Int Immunopharmacol       Date:  2002-04       Impact factor: 4.932

Review 5.  The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.

Authors:  H Harizi; N Gualde
Journal:  Tissue Antigens       Date:  2005-06

Review 6.  Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Authors:  Mairi C Noverr; John R Erb-Downward; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 7.  Paracoccidioidomycosis: an update.

Authors:  E Brummer; E Castaneda; A Restrepo
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

8.  Prostaglandin E(2) production by high and low virulent strains of Paracoccidioides brasiliensis.

Authors:  Ana Paula Bordon; Luciane Alarcão Dias-Melicio; Michele Janegitz Acorci; Guilherme Augusto Biondo; Denise Fecchio; Maria Terezinha Serrão Peraçoli; Angela Maria Victoriano Campos de Soares
Journal:  Mycopathologia       Date:  2007-03-15       Impact factor: 2.574

9.  The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis.

Authors:  L M Singer-Vermes; M C Ciavaglia; S S Kashino; E Burger; V L Calich
Journal:  J Med Vet Mycol       Date:  1992

Review 10.  An overview of the immunopathology of human paracoccidioidomycosis.

Authors:  Gil Benard
Journal:  Mycopathologia       Date:  2008 Apr-May       Impact factor: 2.574

View more
  6 in total

Review 1.  Production of cross-kingdom oxylipins by pathogenic fungi: An update on their role in development and pathogenicity.

Authors:  Gregory J Fischer; Nancy P Keller
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

2.  Severe Paracoccidioidomycosis in a 14-Year-Old Boy.

Authors:  L P Ruas; R M Pereira; F G Braga; X T Lima; R L Mamoni; M L Cintra; A Z Schreiber; V L G Calich; M H S L Blotta
Journal:  Mycopathologia       Date:  2016-06-30       Impact factor: 2.574

Review 3.  Arachidonic acid metabolites in pathogenic yeasts.

Authors:  Ruan Ells; Johan Lf Kock; Jacobus Albertyn; Carolina H Pohl
Journal:  Lipids Health Dis       Date:  2012-08-08       Impact factor: 3.876

4.  Role of omega-3 polyunsaturated fatty acids in the production of prostaglandin E2 and nitric oxide during experimental murine paracoccidioidomycosis.

Authors:  S C Sargi; M M O Dalalio; A G Moraes; J E L Visentainer; D R Morais; J V Visentainer
Journal:  Biomed Res Int       Date:  2013-12-25       Impact factor: 3.411

5.  Lipoxin Inhibits Fungal Uptake by Macrophages and Reduces the Severity of Acute Pulmonary Infection Caused by Paracoccidioides brasiliensis.

Authors:  Laura R R Ribeiro; Flávio V Loures; Eliseu F de Araújo; Cláudia Feriotti; Tânia A Costa; Carlos Henrique Serezani; Sonia Jancar; Vera L G Calich
Journal:  Mediators Inflamm       Date:  2015-10-08       Impact factor: 4.711

6.  43 kDa Glycoprotein (gp43) from Paracoccidioides brasiliensis Induced IL-17A and PGE2 Production by Human Polymorphonuclear Neutrophils: Involvement of TLR2 and TLR4.

Authors:  Taiane Priscila Gardizani; Amanda Manoel Della Coletta; Graziela Gorete Romagnoli; Rosana Puccia; Ana Paula Moreira Serezani; Ângela Maria Victoriano de Campos Soares; Luciane Alarcão Dias-Melicio
Journal:  J Immunol Res       Date:  2019-11-26       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.